Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nagaileben CoTSE:7447 -0.06%65 EBIT per Share is 円114.95 as of Feb. 2026. GuruFocus rates TSE:7447 with a GF Score™ of 65/100 and a GF Value™ of 円2,264.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 825 Manufacturing - Apparel & Accessories companies, Nagaileben Co ranks worse than 65.58% on this metric.
Nagaileben Co's EBIT per Share for the
three
months ended in Feb. 2026 was 円32.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円114.95.
During the past 12 months, the average EBIT per Share Growth Rate of Nagaileben Co was -8.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -9.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -5.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -1.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nagaileben Co's EBIT per Share or its related term are showing as below:
TSE:7447'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.3 Med: 0.75 Max: 31.2
Current: -9.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nagaileben Co was 31.20% per year. The lowest was -19.30% per year. And the median was 0.75% per year.
TSE:7447's 3-Year EBIT Growth Rate is ranked worse than 65.58% of 825
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 0.8
vs TSE:7447: -9.10
Nagaileben Co's EBIT for the
three
months ended in Feb. 2026 was 円969 Mil.
Nagaileben Co (TSE:7447) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nagaileben Co EBIT per Share Related Terms
Nagaileben Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nagaileben Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円114.95
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nagaileben Co (TSE:7447) has a EBIT per Share of 円114.95 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nagaileben Co and its competitors. According to the industry distribution chart, Nagaileben Co ranks #541 out of 825 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 65.6%.
Is Nagaileben Co's EBIT per Share too high?
Nagaileben Co's current EBIT per Share is 円114.95. Based on the distribution chart, Nagaileben Co ranks #541 out of 825 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Nagaileben Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nagaileben Co's EBIT per Share compare to RL and LEVI?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Nagaileben Co ranks #541 out of 825 companies for EBIT per Share. This places Nagaileben Co in the lower half of its industry. The industry median EBIT per Share is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Manufacturing - Apparel & Accessories company?
The median EBIT per Share among Manufacturing - Apparel & Accessories companies is 0.80, based on 825 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nagaileben Co and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EBIT per Share is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nagaileben Co's current EBIT per Share is 円114.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nagaileben Co stock overvalued right now?
Based on GuruFocus' analysis, Nagaileben Co (TSE:7447) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,264.38, compared to a current price of 円1,751.00 — trading 22.7% below its estimated fair value. The current EBIT per Share is 円114.95. Nagaileben Co's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nagaileben Co (TSE:7447), the current EBIT per Share is 円114.95 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nagaileben Co (TSE:7447) Overvalued in 2026?
Based on GuruFocus' analysis, Nagaileben Co stock appears to be undervalued.
The current stock price of 円1,751.00 is trading 22.7% below its estimated GF Value™ of 円2,264.38.
GuruFocus considers Nagaileben Co to be Modestly Undervalued.
Key valuation signals for TSE:7447:
EBIT per Share: 円114.95
GF Value™: 円2,264.38 vs. price of 円1,751.00 (22.7% below fair value)
No single metric tells the full story. See the TSE:7447 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nagaileben Co Ltd manufactures and sells medical clothing and shoes for doctors, dentists, pharmacists, nursing staff, patients, and care workers. Nearly all the company's sales are in Japan, with more than half of total sales in east Japan and the remaining Japanese sales in central Japan and west Japan. The company's six item segments are healthcare wear, surgery wear, doctor wear, utility wear, patient wear, and shoes. Healthcare wear accounts for more than half of total company revenue. Doctors' wear, patient wear, and surgery wear constitute most of the remaining revenue. The company manufactures its products in Japan and Indonesia.
65GF Score
Get the complete analysis for TSE:7447
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7447 has been successfully added to your 
